Heidi Irma Louisa Jacobs, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Locus Coeruleus | 30 | 2024 | 243 | 12.700 |
Why?
|
Alzheimer Disease | 79 | 2024 | 8747 | 7.240 |
Why?
|
tau Proteins | 40 | 2024 | 2143 | 4.830 |
Why?
|
Amyloid beta-Peptides | 47 | 2024 | 3910 | 3.510 |
Why?
|
Positron-Emission Tomography | 43 | 2024 | 6670 | 2.690 |
Why?
|
Parietal Lobe | 9 | 2024 | 866 | 2.030 |
Why?
|
Memory | 11 | 2022 | 2210 | 1.810 |
Why?
|
Hypopigmentation | 2 | 2024 | 43 | 1.730 |
Why?
|
Magnetic Resonance Imaging | 65 | 2024 | 36849 | 1.660 |
Why?
|
Norepinephrine | 5 | 2022 | 900 | 1.630 |
Why?
|
Parahippocampal Gyrus | 4 | 2020 | 118 | 1.290 |
Why?
|
Brain | 45 | 2024 | 27454 | 1.210 |
Why?
|
Hippocampus | 12 | 2024 | 3784 | 1.140 |
Why?
|
Cognition | 19 | 2024 | 7075 | 1.130 |
Why?
|
Atrophy | 9 | 2024 | 1648 | 1.030 |
Why?
|
Glial Fibrillary Acidic Protein | 2 | 2024 | 559 | 1.000 |
Why?
|
Rest | 2 | 2024 | 951 | 0.990 |
Why?
|
Entorhinal Cortex | 3 | 2024 | 288 | 0.990 |
Why?
|
Temporal Lobe | 12 | 2024 | 1728 | 0.980 |
Why?
|
Cerebral Cortex | 11 | 2024 | 5831 | 0.910 |
Why?
|
Brain Mapping | 19 | 2022 | 6740 | 0.890 |
Why?
|
Arteriolosclerosis | 1 | 2023 | 21 | 0.850 |
Why?
|
Solitary Nucleus | 2 | 2021 | 54 | 0.840 |
Why?
|
Cognition Disorders | 8 | 2018 | 3985 | 0.830 |
Why?
|
Aged | 83 | 2024 | 171562 | 0.790 |
Why?
|
Cerebellum | 3 | 2023 | 1514 | 0.780 |
Why?
|
Aged, 80 and over | 48 | 2024 | 59686 | 0.770 |
Why?
|
Aniline Compounds | 9 | 2024 | 1094 | 0.770 |
Why?
|
Memory Disorders | 5 | 2023 | 1203 | 0.760 |
Why?
|
Longevity | 2 | 2020 | 1077 | 0.750 |
Why?
|
Salivary alpha-Amylases | 1 | 2021 | 16 | 0.730 |
Why?
|
Neural Pathways | 9 | 2024 | 3121 | 0.720 |
Why?
|
Neuropsychological Tests | 18 | 2024 | 7145 | 0.720 |
Why?
|
Actigraphy | 1 | 2024 | 526 | 0.720 |
Why?
|
CADASIL | 1 | 2021 | 83 | 0.710 |
Why?
|
Apolipoproteins E | 4 | 2022 | 1459 | 0.700 |
Why?
|
Disease Progression | 17 | 2024 | 13646 | 0.680 |
Why?
|
Autopsy | 5 | 2024 | 1013 | 0.680 |
Why?
|
Blood-Brain Barrier | 5 | 2019 | 1033 | 0.670 |
Why?
|
Saliva | 2 | 2021 | 854 | 0.640 |
Why?
|
Aging | 12 | 2024 | 8764 | 0.610 |
Why?
|
Nerve Net | 4 | 2021 | 2362 | 0.600 |
Why?
|
Leukoencephalopathies | 1 | 2021 | 260 | 0.600 |
Why?
|
Sex Characteristics | 5 | 2024 | 2660 | 0.600 |
Why?
|
Sympathetic Nervous System | 1 | 2021 | 521 | 0.590 |
Why?
|
Cerebral Amyloid Angiopathy | 2 | 2023 | 892 | 0.590 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2022 | 607 | 0.580 |
Why?
|
Leukoaraiosis | 1 | 2018 | 115 | 0.570 |
Why?
|
Male | 89 | 2024 | 364902 | 0.550 |
Why?
|
Nerve Fibers, Myelinated | 2 | 2014 | 953 | 0.550 |
Why?
|
Executive Function | 5 | 2023 | 1405 | 0.550 |
Why?
|
Humans | 126 | 2024 | 768393 | 0.540 |
Why?
|
Astrocytes | 1 | 2024 | 1349 | 0.530 |
Why?
|
Mental Processes | 3 | 2019 | 247 | 0.520 |
Why?
|
Female | 85 | 2024 | 397089 | 0.520 |
Why?
|
Thiazoles | 7 | 2024 | 1542 | 0.510 |
Why?
|
Attention | 7 | 2024 | 2425 | 0.510 |
Why?
|
Carbolines | 6 | 2024 | 296 | 0.480 |
Why?
|
Middle Aged | 55 | 2024 | 223491 | 0.470 |
Why?
|
Peptide Fragments | 7 | 2024 | 5151 | 0.470 |
Why?
|
Vascular Diseases | 1 | 2023 | 1161 | 0.470 |
Why?
|
Learning | 3 | 2021 | 1761 | 0.450 |
Why?
|
Transcutaneous Electric Nerve Stimulation | 1 | 2015 | 170 | 0.410 |
Why?
|
Neurofibrillary Tangles | 3 | 2024 | 459 | 0.410 |
Why?
|
Dementia | 4 | 2019 | 2729 | 0.410 |
Why?
|
Longitudinal Studies | 19 | 2024 | 14784 | 0.410 |
Why?
|
Tauopathies | 3 | 2021 | 328 | 0.400 |
Why?
|
Vagus Nerve | 1 | 2015 | 460 | 0.400 |
Why?
|
Visual Perception | 3 | 2019 | 1406 | 0.390 |
Why?
|
Frontal Lobe | 4 | 2024 | 1428 | 0.380 |
Why?
|
Vagus Nerve Stimulation | 1 | 2015 | 229 | 0.380 |
Why?
|
Methoxyhydroxyphenylglycol | 2 | 2021 | 93 | 0.370 |
Why?
|
Diffusion Magnetic Resonance Imaging | 2 | 2024 | 2820 | 0.360 |
Why?
|
Organ Size | 6 | 2021 | 2268 | 0.360 |
Why?
|
Image Processing, Computer-Assisted | 10 | 2017 | 9063 | 0.350 |
Why?
|
Asymptomatic Diseases | 3 | 2024 | 589 | 0.340 |
Why?
|
Amnesia | 1 | 2012 | 258 | 0.340 |
Why?
|
Reaction Time | 5 | 2019 | 2103 | 0.310 |
Why?
|
Space Perception | 1 | 2012 | 467 | 0.310 |
Why?
|
Pattern Recognition, Automated | 1 | 2015 | 998 | 0.310 |
Why?
|
Diffusion Tensor Imaging | 5 | 2021 | 2426 | 0.290 |
Why?
|
Models, Neurological | 5 | 2021 | 1783 | 0.280 |
Why?
|
Circadian Rhythm | 3 | 2024 | 2588 | 0.270 |
Why?
|
Cognitive Reserve | 2 | 2024 | 92 | 0.270 |
Why?
|
Presenilin-1 | 2 | 2022 | 665 | 0.270 |
Why?
|
Stress, Psychological | 1 | 2021 | 4543 | 0.240 |
Why?
|
Cross-Sectional Studies | 11 | 2024 | 26375 | 0.240 |
Why?
|
Functional Laterality | 4 | 2018 | 2268 | 0.230 |
Why?
|
Fluorodeoxyglucose F18 | 3 | 2024 | 2056 | 0.230 |
Why?
|
Apolipoprotein E4 | 5 | 2020 | 711 | 0.230 |
Why?
|
Olfactory Perception | 1 | 2024 | 65 | 0.220 |
Why?
|
Reflex, Pupillary | 1 | 2023 | 62 | 0.220 |
Why?
|
Software | 2 | 2015 | 4453 | 0.220 |
Why?
|
Adult | 25 | 2024 | 223640 | 0.210 |
Why?
|
Pupil | 1 | 2023 | 146 | 0.210 |
Why?
|
Substantia Nigra | 2 | 2023 | 348 | 0.200 |
Why?
|
Neurofilament Proteins | 1 | 2024 | 337 | 0.200 |
Why?
|
Melanins | 2 | 2023 | 289 | 0.200 |
Why?
|
Parkinson Disease | 3 | 2023 | 2895 | 0.200 |
Why?
|
Neurites | 1 | 2024 | 390 | 0.200 |
Why?
|
Radiopharmaceuticals | 4 | 2020 | 2734 | 0.200 |
Why?
|
Cerebrovascular Circulation | 1 | 2011 | 2736 | 0.190 |
Why?
|
Young Adult | 15 | 2023 | 60049 | 0.180 |
Why?
|
alpha-Amylases | 1 | 2020 | 39 | 0.180 |
Why?
|
Gyrus Cinguli | 2 | 2018 | 1137 | 0.180 |
Why?
|
Dementia, Vascular | 1 | 2021 | 125 | 0.170 |
Why?
|
Sleep, REM | 1 | 2023 | 595 | 0.170 |
Why?
|
Extracellular Fluid | 1 | 2021 | 165 | 0.170 |
Why?
|
Linear Models | 4 | 2021 | 5878 | 0.170 |
Why?
|
Widowhood | 1 | 2020 | 51 | 0.170 |
Why?
|
Psychomotor Performance | 2 | 2018 | 1895 | 0.170 |
Why?
|
Nerve Degeneration | 2 | 2021 | 750 | 0.170 |
Why?
|
Cell Count | 1 | 2024 | 1833 | 0.170 |
Why?
|
Acetylcholinesterase | 1 | 2019 | 151 | 0.160 |
Why?
|
Amyloidogenic Proteins | 1 | 2020 | 154 | 0.160 |
Why?
|
Extravasation of Diagnostic and Therapeutic Materials | 1 | 2019 | 101 | 0.160 |
Why?
|
Activity Cycles | 1 | 2018 | 47 | 0.150 |
Why?
|
Acetates | 1 | 2019 | 317 | 0.150 |
Why?
|
Judgment | 1 | 2020 | 272 | 0.150 |
Why?
|
Light | 1 | 2023 | 1354 | 0.140 |
Why?
|
Early Diagnosis | 2 | 2012 | 1195 | 0.140 |
Why?
|
Social Behavior | 1 | 2024 | 1146 | 0.140 |
Why?
|
Social Participation | 1 | 2019 | 187 | 0.140 |
Why?
|
Cues | 2 | 2019 | 884 | 0.140 |
Why?
|
Brain Stem | 1 | 2022 | 862 | 0.130 |
Why?
|
Sleep | 3 | 2023 | 4802 | 0.130 |
Why?
|
Plaque, Amyloid | 1 | 2020 | 769 | 0.130 |
Why?
|
Loneliness | 1 | 2018 | 211 | 0.130 |
Why?
|
Contrast Media | 5 | 2020 | 5336 | 0.130 |
Why?
|
Affect | 1 | 2023 | 1501 | 0.130 |
Why?
|
Ethylene Glycols | 3 | 2024 | 198 | 0.120 |
Why?
|
Choroid Plexus | 1 | 2018 | 250 | 0.120 |
Why?
|
Pilot Projects | 2 | 2021 | 8731 | 0.120 |
Why?
|
Gadolinium | 1 | 2019 | 965 | 0.110 |
Why?
|
Cyclophosphamide | 1 | 2019 | 2226 | 0.110 |
Why?
|
Auditory Perception | 1 | 2018 | 588 | 0.110 |
Why?
|
Arousal | 1 | 2019 | 1183 | 0.110 |
Why?
|
Nerve Fibers, Unmyelinated | 1 | 2013 | 98 | 0.110 |
Why?
|
Image Enhancement | 2 | 2020 | 2894 | 0.100 |
Why?
|
Heterozygote | 1 | 2019 | 2791 | 0.100 |
Why?
|
Cohort Studies | 4 | 2024 | 41795 | 0.100 |
Why?
|
Severity of Illness Index | 4 | 2018 | 15939 | 0.100 |
Why?
|
Corpus Striatum | 1 | 2018 | 1237 | 0.100 |
Why?
|
Seizures | 1 | 2024 | 3000 | 0.090 |
Why?
|
Hypertension | 1 | 2011 | 8615 | 0.090 |
Why?
|
Single-Blind Method | 1 | 2015 | 1585 | 0.090 |
Why?
|
Electroencephalography | 2 | 2024 | 6317 | 0.090 |
Why?
|
Inflammation | 2 | 2022 | 10863 | 0.090 |
Why?
|
Cerebrovascular Disorders | 1 | 2017 | 1486 | 0.090 |
Why?
|
PubMed | 1 | 2011 | 130 | 0.090 |
Why?
|
Piperidines | 1 | 2019 | 1659 | 0.090 |
Why?
|
Principal Component Analysis | 1 | 2014 | 948 | 0.090 |
Why?
|
Imagination | 1 | 2012 | 226 | 0.090 |
Why?
|
Placebos | 1 | 2015 | 1668 | 0.090 |
Why?
|
Risk | 2 | 2019 | 9636 | 0.090 |
Why?
|
Amyloidosis | 1 | 2018 | 879 | 0.090 |
Why?
|
Mental Status Schedule | 1 | 2011 | 315 | 0.090 |
Why?
|
Neurodegenerative Diseases | 1 | 2019 | 1094 | 0.090 |
Why?
|
Brain Injuries | 1 | 2022 | 2059 | 0.090 |
Why?
|
Computers | 1 | 2012 | 592 | 0.080 |
Why?
|
Interleukin-6 | 1 | 2019 | 3230 | 0.080 |
Why?
|
Colombia | 2 | 2021 | 287 | 0.080 |
Why?
|
Anxiety | 1 | 2024 | 4677 | 0.080 |
Why?
|
Anisotropy | 1 | 2012 | 1296 | 0.080 |
Why?
|
Heart Rate | 1 | 2020 | 4218 | 0.080 |
Why?
|
Cross-Over Studies | 1 | 2015 | 2106 | 0.080 |
Why?
|
Animals | 5 | 2023 | 169337 | 0.070 |
Why?
|
Brain Ischemia | 1 | 2020 | 3008 | 0.070 |
Why?
|
Radionuclide Imaging | 1 | 2011 | 1998 | 0.070 |
Why?
|
Biological Evolution | 1 | 2013 | 1078 | 0.070 |
Why?
|
Amyloid | 2 | 2024 | 854 | 0.070 |
Why?
|
Predictive Value of Tests | 2 | 2021 | 15455 | 0.060 |
Why?
|
Gadolinium DTPA | 2 | 2020 | 823 | 0.060 |
Why?
|
Causality | 1 | 2012 | 1255 | 0.060 |
Why?
|
Depressive Disorder, Major | 1 | 2023 | 4819 | 0.060 |
Why?
|
Photic Stimulation | 2 | 2023 | 2004 | 0.060 |
Why?
|
Neurons | 1 | 2024 | 9513 | 0.060 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2018 | 3411 | 0.060 |
Why?
|
Time Factors | 3 | 2018 | 40272 | 0.050 |
Why?
|
Age Factors | 1 | 2020 | 18471 | 0.050 |
Why?
|
Olfactory Pathways | 1 | 2024 | 133 | 0.050 |
Why?
|
ROC Curve | 1 | 2011 | 3623 | 0.050 |
Why?
|
Smell | 1 | 2024 | 261 | 0.050 |
Why?
|
Prognosis | 2 | 2021 | 30022 | 0.050 |
Why?
|
Data Interpretation, Statistical | 1 | 2012 | 2708 | 0.050 |
Why?
|
Retrospective Studies | 3 | 2024 | 81801 | 0.050 |
Why?
|
Phantoms, Imaging | 2 | 2020 | 2528 | 0.050 |
Why?
|
Capsaicin | 1 | 2021 | 235 | 0.040 |
Why?
|
Epilepsies, Partial | 1 | 2024 | 435 | 0.040 |
Why?
|
Neocortex | 1 | 2024 | 417 | 0.040 |
Why?
|
Adolescent | 6 | 2019 | 89184 | 0.040 |
Why?
|
Spectrum Analysis | 1 | 2021 | 449 | 0.040 |
Why?
|
Occipital Lobe | 1 | 2020 | 376 | 0.040 |
Why?
|
Reflex | 1 | 2020 | 375 | 0.040 |
Why?
|
Exudates and Transudates | 1 | 2019 | 175 | 0.040 |
Why?
|
Stroke | 1 | 2020 | 9742 | 0.040 |
Why?
|
Physical Stimulation | 1 | 2019 | 517 | 0.040 |
Why?
|
Socioeconomic Factors | 1 | 2012 | 7861 | 0.040 |
Why?
|
RNA, Messenger | 1 | 2013 | 12805 | 0.040 |
Why?
|
Mutation | 1 | 2022 | 30228 | 0.040 |
Why?
|
Databases, Factual | 1 | 2013 | 8075 | 0.040 |
Why?
|
Wakefulness | 1 | 2023 | 1283 | 0.030 |
Why?
|
Fibrin | 1 | 2019 | 514 | 0.030 |
Why?
|
Prospective Studies | 4 | 2023 | 54920 | 0.030 |
Why?
|
Cold Temperature | 1 | 2019 | 786 | 0.030 |
Why?
|
Blood Pressure | 1 | 2011 | 8541 | 0.030 |
Why?
|
Semantics | 1 | 2019 | 618 | 0.030 |
Why?
|
Capillary Permeability | 1 | 2019 | 773 | 0.030 |
Why?
|
Models, Biological | 1 | 2011 | 9493 | 0.030 |
Why?
|
Sex Factors | 2 | 2019 | 10654 | 0.030 |
Why?
|
Cell Nucleus | 1 | 2023 | 2886 | 0.030 |
Why?
|
Microvessels | 1 | 2019 | 586 | 0.030 |
Why?
|
Melanocytes | 1 | 2018 | 508 | 0.030 |
Why?
|
Menopause | 1 | 2022 | 1653 | 0.030 |
Why?
|
Acoustic Stimulation | 1 | 2018 | 1253 | 0.030 |
Why?
|
Risk Factors | 3 | 2020 | 74962 | 0.030 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2019 | 1141 | 0.030 |
Why?
|
Blood Proteins | 1 | 2019 | 1186 | 0.030 |
Why?
|
Diazepam Binding Inhibitor | 1 | 2013 | 5 | 0.030 |
Why?
|
Consensus | 1 | 2023 | 3212 | 0.030 |
Why?
|
Mice | 1 | 2019 | 82017 | 0.020 |
Why?
|
Emotions | 1 | 2023 | 2768 | 0.020 |
Why?
|
Forecasting | 1 | 2020 | 2948 | 0.020 |
Why?
|
Perception | 1 | 2017 | 1205 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2018 | 1901 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2017 | 6241 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2020 | 39407 | 0.020 |
Why?
|
Boston | 1 | 2021 | 9371 | 0.020 |
Why?
|
Alternative Splicing | 1 | 2013 | 1093 | 0.020 |
Why?
|
Self Report | 1 | 2018 | 3766 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2019 | 4570 | 0.020 |
Why?
|
Brain Concussion | 1 | 2018 | 1433 | 0.020 |
Why?
|
Phosphorylation | 1 | 2017 | 8326 | 0.020 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2017 | 6034 | 0.020 |
Why?
|
Life Style | 1 | 2018 | 3929 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2019 | 12092 | 0.020 |
Why?
|
Cerebral Hemorrhage | 1 | 2017 | 2653 | 0.020 |
Why?
|
Oxygen | 1 | 2017 | 4273 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2013 | 2038 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2020 | 22296 | 0.010 |
Why?
|
Quality of Life | 1 | 2023 | 13503 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2013 | 14737 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2019 | 18048 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2020 | 20765 | 0.010 |
Why?
|
Child | 1 | 2019 | 80891 | 0.010 |
Why?
|